Loading clinical trials...
Loading clinical trials...
A Phase 2, Placebo Controlled, Randomized, Double-Blind, Parallel-Arm Study to Evaluate Efficacy and Safety of BMS- 986141 For the Prevention of Recurrent Brain Infarction in Subjects Receiving Acetylsalicylic Acid (ASA) Following Acute Ischemic Stroke or Transient Ischemic Attack
Conditions
Interventions
BMS-986141
Aspirin
+1 more
Locations
33
United States
Banner University Medical Ctr
Phoenix, Arizona, United States
Hoag Memorial Hospital
Newport Beach, California, United States
Local Institution
Newark, Delaware, United States
University Of Florida
Gainesville, Florida, United States
University Of Florida Hsc/Jacksonville
Jacksonville, Florida, United States
Florida Hospital
Orlando, Florida, United States
Start Date
April 25, 2016
Primary Completion Date
March 31, 2017
Completion Date
March 31, 2017
Last Updated
December 14, 2018
NCT07410117
NCT03830320
NCT07102160
NCT06658197
NCT05628948
NCT05967741
Lead Sponsor
Bristol-Myers Squibb
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions